Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation

Pediatric Research

Volumn 48, Issue 2, 2000, Pages 233-237

  Orvisky, Eduard ^a   Sidransky, Ellen ^a   McKinney, Cindy E ^a   LaMarca, Mary E ^a   Samimi, Roxana ^a   Krasnewich, Donna ^a   Martin, Brian M ^a   Ginns, Edward I ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE; SPHINGOSINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; EMBRYO; ENZYME DEFICIENCY; FEMALE; FETUS; GAUCHER DISEASE; GENE THERAPY; GESTATION PERIOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYMPTOM;

EID: 0033916912     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200008000-00018     Document Type: Article

References (30)

1. Metabolism of glucocerebrosides II: Evidence of an enzymatic deficiency in Gaucher's disease
2. A reinvestigation of the cerebroside deposited in Gaucher's disease
3. Infantile Gaucher's disease: A case with neuronal storage
4. Neuronopathic forms of Gaucher's disease
5. Enzymatic hydrolysis of sphingolipids. I. Hydrolysis and synthesis of ceramides by an enzyme from rat brain
6. Purification, characterization, and biosynthesis of human acid ceramidase
7. Glucosylceramide lipidoses: Gaucher's disease
8. New perspectives in type 2 Gaucher disease
9. Pathology of Gaucher disease
10. Glucosylceramide lipidoses: Gaucher disease
11. Gaucher disease: Gene frequencies and genotype/phenotype correlations
12. DNA mutational analysis of type 1 and type 3 Gaucher patients: How well do mutations predict phenotype?
13. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease
14. Lysosphingolipids inhibit protein kinase C: Implications for the sphingolipidoses
15. Sphingolipid metabolism and cell growth regulation
16. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene
17. A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse
18. Gaucher disease: A tale of two species
19. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus
20. Novel procedure for measuring psychosine derivatives by an HPLC method
21. Globoid cell leukodystrophy: Additional deficiency of psychosine galactosidase
22. Twenty five years of the 'Psychosine Hypothesis': A personal perspective of its history and present status
23. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease
24. Glucosylsphingosine accumulation in patients with Gaucher disease
25. Chemical differentiation of the Gaucher subtypes
26. The sphingomyelin cycle and the second messenger function of ceramide
27. Accumulation of tissue glucosylsphingosine in Gancher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol
28. Inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids